Valeo Pharmainc (VPH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Sales | 12,601 | 14,129 | 13,539 | 13,108 | 14,082 |
| Cost of Goods | 9,567 | 11,239 | 11,281 | 12,476 | 9,812 |
| Gross Profit | 3,034 | 2,890 | 2,258 | 632 | 4,270 |
| Operating Expenses | 5,617 | 6,782 | 7,121 | 7,766 | 7,700 |
| Operating Income | -2,583 | -3,892 | -4,863 | -7,134 | -3,430 |
| Interest Expense | 3,974 | 3,843 | 3,806 | 3,755 | 3,454 |
| Other Income | -1,635 | -76 | 1,797 | 1,644 | 1,046 |
| Pre-tax Income | -8,192 | -7,811 | -6,872 | -9,245 | -5,838 |
| Net Income Continuous | -8,192 | -7,811 | -6,872 | -9,245 | -5,838 |
| Net Income | $-8,192 | $-7,811 | $-6,872 | $-9,245 | $-5,838 |
| EPS Basic Total Ops | -0.08 | -0.08 | -0.08 | -0.10 | -0.07 |
| EPS Basic Continuous Ops | -0.08 | -0.08 | -0.08 | -0.10 | -0.07 |
| EPS Diluted Total Ops | -0.08 | -0.08 | -0.08 | -0.10 | -0.07 |
| EPS Diluted Continuous Ops | -0.08 | -0.08 | -0.08 | -0.10 | -0.07 |
| EBITDA(a) | $-3,592 | $-3,331 | $-2,414 | $-4,739 | $-1,754 |